13F Insight
DOSSIER · 13F-HR · Q2 2026

SUMMER ROAD LLC

$142M in tracked AUM across 24 positions as of Q2 2026.

SR
CIK 0001604873 · last filed Jun 30, 2026
Total AUM
$142M
as of Q2 2026
Holdings
24
—
positions
Whale Score
69
69
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

Ocular Therapeutix and Ingles Markets dominate a book that was effectively a one-stock portfolio last quarter and is now a concentrated two-stock bet. OCUL still commands 70.8% despite a dollar decline, while a $171K token position in IMKTA was built into a $39M second name in a single quarter. Here is what that concentration pattern tells us.

The Core Concentration

Ocular Therapeutix (OCUL) was 97.9% of the portfolio heading into this quarter — a near-total single-stock bet that by itself already marked this as an outlier filing. The stock has underperformed in dollar terms, with the position declining from $134.9M to $100.6M, but the share count actually increased from 11.1M to 11.9M — meaning Summer Road continued buying into the drawdown. That is a present-tense signal of conviction that is rare at this level of prior concentration: the manager is not de-risking out of a dominant position; they are accumulating through weakness. The 70.8% remaining weight is still massive, but it is a concentration in transition rather than a stable static bet.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
OCUL
OCULAR THERAPEUTIX INC
$120M12.2M74.5%02
IMKTA
INGLES MKTS INC
$38M434K23.9%03
LINE
LINEAGE INC
$883K20K0.5%04
GRBK
GREEN BRICK PARTNERS INC
$284K4K0.2%05
GOOGL
ALPHABET INC
$261K7300.2%06
GDX
VANECK ETF TRUST
$202K3K0.1%07
DIS
DISNEY WALT CO
$177K2K0.1%08
CTRE
CARETRUST REIT INC
$151K4K0.1%09
GLD
SPDR GOLD TR
$123K3340.1%10
SBCF
SEACOAST BKG CORP FLA
$105K3K0.1%

Filing history

2026Q2Jun 30
$161M▲ 13.4%
21 positionsView →2026Q1Mar 31
$142M▲ 3.1%
24 positionsView →2025Q4Dec 31
$138M▼ 7.7%
21 positionsView →2025Q3Sep 30
$149M▲ 13.7%
19 positionsView →2025Q2Jun 30
$131M▲ 26.7%
25 positionsLocked2025Q1Mar 31
$104M▲ 86120.8%
25 positionsLocked2024Q4Dec 31
$120K▼ 99.9%
25 positionsLocked2024Q3Sep 30
$127M▲ 22.9%
26 positionsLocked2024Q2Jun 30
$103M▲ 78967.3%
29 positionsLocked2024Q1Mar 31
$131K▲ 282.5%
1 positionsLocked2023Q4Dec 31
$34K▲ 77.7%
1 positionsLocked2023Q3Sep 30
$19K▼ 39.1%
1 positionsLocked
Showing 12 of 44